Is there an established hemoglobin target range for patients undergoing chronic dialysis?

abstract：:A good catheter implantation technique is important to allow for effective peritoneal access function and long-term technique survival. Studies regarding results obtained by nephrologists in comparison with surgeons have been limited to small single-center experiences. Thus, the objective of this study was to explore ...

journal_title：Seminars in dialysis

authors： de Moraes TP,Campos RP,de Alcântara MT,Chula D,Vieira MA,Riella MC,Olandowski M,Divino-Filho JC,Pecoits-Filho R,Investigators of BRAZPD.

更新日期：2012-09-01 00:00:00

abstract：:Nephrologists offer renal replacement therapy (RRT) to patients who are unlikely to benefit in part because of our discomfort discussing goals of care in the setting of an uncertain prognosis for a given individual. Permanent neurological impairment, terminal illness (life expectancy <6 months), medical conditions pre...

journal_title：Seminars in dialysis

authors： Holley JL

更新日期：2016-07-01 00:00:00

abstract：:Pregnancy occurs uncommonly in women with chronic kidney disease (CKD) and fetal outcome tends to be poor, with high rates of prematurity and mortality. Dialysis, by complementing residual renal function, may improve fetal outcome in pregnant women with CKD. Although there are no prospective or randomized trials that ...

journal_title：Seminars in dialysis

authors： Shemin D

更新日期：2003-09-01 00:00:00

abstract：:Presternally exiting peritoneal dialysis (PD) catheters have been described as advantageous compared to abdominally exiting catheters with regard to infection, wound healing, and other complications. Placement of such catheters has only been described with open surgical techniques and not by percutaneous means. In thi...

journal_title：Seminars in dialysis

authors： Sreenarasimhaiah VP,Margassery SK,Martin KJ,Bander SJ

更新日期：2004-09-01 00:00:00

abstract：:Over 60% of patients initiating chronic hemodialysis in the United States have a chronic central venous catheter (CVC) as their first blood access device. Although it would be better if these patients started dialysis with fistulas, the CVC is used because it is a reliable and relatively safe method for obtaining bloo...

journal_title：Seminars in dialysis

authors： Ash SR

更新日期：2007-05-01 00:00:00

abstract：:Cardiovascular complications are the leading cause of mortality in patients with end-stage renal disease (ESRD). The excess cardiovascular risk and mortality is already demonstrable in early renal disease and in patients with chronic renal failure (CRF), with the highest relative risk of mortality in the youngest pati...

journal_title：Seminars in dialysis

authors： London GM

更新日期：2003-03-01 00:00:00

abstract：:Meta-analyses of the published literature are increasingly being used, allowing similar clinical trials to be combined quantitatively, thereby increasing the precision of the estimation of treatment effect. Four meta-analyses were recently published comparing the impact of dialysis membranes or dialysis modality on cl...

journal_title：Seminars in dialysis

authors： Teehan GS,Liangos O,Lau J,Levey AS,Pereira BJ,Jaber BL

更新日期：2003-09-01 00:00:00

abstract：:Renal osteodystrophy (ROD) is a bone disorder that occurs in chronic kidney disease (CKD) patients and is associated with 2- to 14-fold increased fracture risk compared to the general population. Risk of fractures is also increased in kidney transplant recipients especially within the first 5 years after transplantati...

journal_title：Seminars in dialysis

authors： Babayev R,Nickolas TL

更新日期：2015-11-01 00:00:00

abstract：:Translumbar tunneled dialysis catheter (TLDC) is a temporary dialysis access for patients exhausted traditional access for dialysis. While few small studies reported successes with TLDC, additional studies are warranted to understand the short- and long-term patency and safety of TLDC. We conducted a retrospective ana...

journal_title：Seminars in dialysis

authors： Liu F,Bennett S,Arrigain S,Schold J,Heyka R,McLennan G,Navaneethan SD

更新日期：2015-07-01 00:00:00

abstract：:Intravenous iron is an important component of the treatment of anemia of end-stage renal disease (ESRD), but it is biologically plausible that iron could increase the risk of infection through impairment of neutrophil and T-cell function and promotion of microbial growth. Any such increase in risk would be particularl...

journal_title：Seminars in dialysis

authors： Ishida JH,Johansen KL

更新日期：2014-01-01 00:00:00

abstract：:Over the past decade, patients returning to dialysis after a failed transplant comprised of 5-10% of the annual number of dialysis initiations in the United States, whereas retransplant candidates account for 5.0-13% of the annual deceased donor wait-list additions. The United States Renal Data System (USRDS) database...

journal_title：Seminars in dialysis

authors： Pham PT,Pham PC

更新日期：2011-05-01 00:00:00

abstract：:Measurements of the concentration of parathyroid hormone (PTH) in serum or plasma are used widely for the initial diagnostic assessment of patients with renal bone disease, to monitor disease progression, and to gauge responses to treatment. Several analytical methods are used to measure plasma PTH levels, and a varie...

journal_title：Seminars in dialysis

authors： Goodman WG

更新日期：2007-01-01 00:00:00

abstract：:Early versus later start of dialysis is still a matter of debate. Low-protein diets have been used for many decades to delay dialysis initiation. Protein-restricted diets (0.3-0.6 g protein/kg/day) supplemented with essential amino acids and ketoanalogues (sVLPD) can be offered, in association with pharmacological tre...

journal_title：Seminars in dialysis

authors： Aparicio M,Bellizzi V,Chauveau P,Cupisti A,Ecder T,Fouque D,Garneata L,Lin S,Mitch W,Teplan V,Yu X,Zakar G

更新日期：2013-11-01 00:00:00

abstract：:Peritoneal dialysis (PD) is an underutilized form of renal replacement therapy. Recent data have emphasized that only 12% of end-stage renal disease (ESRD) patients are initiated on this form of therapy in the United States. Patients requiring PD have most often been referred to general surgeons for catheter placement...

journal_title：Seminars in dialysis

authors： Asif A,Byers P,Gadalean F,Roth D

更新日期：2003-05-01 00:00:00

abstract：:The elderly people, 65 years old and above, are growing in number. The structural and functional changes associated with aging place the elderly at risk when challenged by extracorporeal therapies, such as therapeutic plasma exchange (TPE). We retrospectively analyzed data on all patients who underwent TPE for renal i...

journal_title：Seminars in dialysis

authors： Hayes JS,Balogun RA,Chang J,Abdel-Rahman EM

更新日期：2012-03-01 00:00:00

abstract：:Iodinated contrast agents are well tolerated in ESRD patients. Certain types of ICM, i.e., LOCM and the nonionic agents are associated with better safety profiles. Current available evidence, although not optimal, does not support the need for additional hemodialysis for ICM removal to preserve residual renal function...

journal_title：Seminars in dialysis

authors： Khan SF,Kalantari K

更新日期：2014-11-01 00:00:00

abstract：:Most recent randomized controlled trials (RCTs) have found that hemodialysis graft surveillance combined with preemptive correction of stenosis does not prolong graft survival. Nevertheless, such programs may be justified if they reduce other adverse outcomes or decrease the cost of care. This study tested this hypoth...

journal_title：Seminars in dialysis

authors： Dossabhoy NR,Ram SJ,Nassar R,Work J,Eason JM,Paulson WD

更新日期：2005-11-01 00:00:00

abstract：:Many dialysis machines can compute dialyzer sodium clearances at multiple time points during a dialysis treatment using conductivity. For a given treatment, the average dialyzer sodium clearance (K), when combined with treatment time (t), and the estimated urea distribution volume (V, usually based on either anthropom...

journal_title：Seminars in dialysis

authors： Daugirdas JT

更新日期：2018-11-01 00:00:00

abstract：:The profile of patients on chronic dialysis has shifted. There is a growing group of older patients with comorbid dementia and ESKD, who are at risk of overuse, underuse, and misuse of dialysis. Policy is lacking to help guide treatment decisions in this group. This paper explores clinical considerations specific to p...

journal_title：Seminars in dialysis

authors： MacPhail A,Ibrahim JE,Fetherstonhaugh D,Levidiotis V

更新日期：2015-09-01 00:00:00

abstract：:Hemodialysis patients are susceptible to coronavirus disease 2019 (COVID-19). The aim of this study was to describe the epidemiological, clinical characteristics, and mortality-related risk factors for those who undergoing hemodialysis with COVID-19. We conducted a retrospective study. A total of 49 hemodialysis patie...

journal_title：Seminars in dialysis

authors： Tian M,Li H,Yan T,Dai Y,Dong L,Wei H,Song X,Dong J,Cheng F,Li W

更新日期：2020-10-29 00:00:00

abstract：:Recombinant human erythropoietin (rHuEPO, epoetin) revolutionized the treatment of anemia in patients with chronic kidney disease (CKD) when it was approved for use in the United States in 1989. Among dialysis patients, the mean hemoglobin (Hb) in patients undergoing dialysis rose from 7-8 g/dl prior to 1989 to 11-12 ...

journal_title：Seminars in dialysis

authors： Berns JS

更新日期：2005-01-01 00:00:00

abstract：:Bedside removal of tunneled hemodialysis catheters (TDC) by noninterventional Nephrologists has not been frequently performed or studied. We performed a retrospective review of bedside TDC removal at the University of Mississippi Medical Center between January, 2010 and June, 2013. We collected data on multiple patien...

journal_title：Seminars in dialysis

authors： Fülöp T,Rodríguez B,Kosztaczky BA,Gharaibeh KA,Lengvárszky Z,Dossabhoy NR,Tapolyai MB

更新日期：2015-09-01 00:00:00

abstract：:Atrial fibrillation, venous thromboembolism, and access malfunction are common clinical problems in dialysis patients that prompt consideration of warfarin therapy. Atrial fibrillation appears to be more common in people with low glomerular filtration rate (GFR) or on dialysis than in the general population, but the r...

journal_title：Seminars in dialysis

authors： Holden RM,Clase CM

更新日期：2009-09-01 00:00:00

abstract：:With the current understanding that atherosclerosis is an inflammatory disorder, markers of the associated systemic inflammatory response have been extensively studied as predictors of cardiovascular disease. Recently the use of high-sensitivity C-reactive protein (hsCRP) has been proposed for risk assessment in indiv...

journal_title：Seminars in dialysis

authors： Rao M,Jaber BL,Balakrishnan VS

更新日期：2006-03-01 00:00:00

abstract：:Dialysis vascular access associated coronary-subclavian steal or hypoperfusion syndrome is an uncommon but potentially life threatening condition. Awareness of this syndrome is important in the management of vascular access in hemodialysis patients. We report a case of dialysis vascular access associated coronary-subc...

journal_title：Seminars in dialysis

authors： Tan CS,Fintelmann F,Joe J,Ganguli S,Wu S

更新日期：2013-09-01 00:00:00

abstract：:Central vein catheters for dialysis have become an integral and unavoidable access modality for providing hemodialysis therapy despite all their major drawbacks. We report a clinical decision dilemma that every nephrologist will encounter while considering an ideal dialysis access for the steadily aging dialysis popul...

journal_title：Seminars in dialysis

authors： Vachharajani TJ,Moossavi S,Kaufman T,Rocco M

更新日期：2009-09-01 00:00:00

abstract：:Alternate night nocturnal hemodialysis (HD) is a popular modality in Australia. This modality grew out of a desire to increase the availability and accessibility of nocturnal HD without incurring excessive costs. It has proven popular with staff, patients, and administrators. There are limited data to support the bene...

journal_title：Seminars in dialysis

authors： Kerr PG,Agar JW,Hawley CM

更新日期：2011-11-01 00:00:00

abstract：:Cardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide. Although numerous modifiable risk factors in the pathogenesis of CVD and its associated mortality have been identified, dyslipidemia remains to be a key focus for therapy. In this regard, significant progress has been made in reducing ...

journal_title：Seminars in dialysis

authors： Moradi H,Streja E,Vaziri ND

更新日期：2018-07-01 00:00:00

abstract：:Until the discovery of calcimimetics, the management of secondary hyperparathyroidism (SHPT) relied exclusively on treatment with phosphate binders, vitamin D derivatives or surgical parathyroidectomy with limited success. The therapeutic use of calcimimetic agents, together with a better understanding of the pivotal ...

journal_title：Seminars in dialysis

authors： Rodríguez M,Goodman WG,Liakopoulos V,Messa P,Wiecek A,Cunningham J

更新日期：2015-09-01 00:00:00

abstract：:Despite having thousands of blood pressure (BP) readings on individual dialysis patients over the course of a year, our knowledge about the optimal assessment of BP, the mechanisms underlying hypertension and its management remain incomplete. Observational studies reveal that BP is lower at home than when measured in ...

journal_title：Seminars in dialysis

authors： Miskulin DC,Weiner DE

更新日期：2017-05-01 00:00:00